Trial Profile

Facilitated Immunoglobulin Administration Registry and Outcomes Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Immune globulin (Primary)
Indications Immunodeficiency disorders
Focus Adverse reactions
Acronyms FIGARO
Sponsors GWT-TUD GmbH

Most Recent Events

27 Jul 2021 Status changed from active, no longer recruiting to completed.
17 Jun 2021 Interim results (n=156; as of 2 Feb 2021) presented at the 26th Congress of the European Haematology Association
01 Feb 2021 Planned number of patients changed from 100 to 154.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com